Loading...
OCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer
McNeish, IA Moreno, V Jayson, Gordon C Roxburgh, P Ginesta, MPB Garcia-Donas, J Torres, AA Michael, A Brown, R Krige, D
McNeish, IA
Moreno, V
Jayson, Gordon C
Roxburgh, P
Ginesta, MPB
Garcia-Donas, J
Torres, AA
Michael, A
Brown, R
Krige, D
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
McNeish IA, Moreno V, Jayson G, Roxburgh P, Ginesta MPB, Garcia-Donas J, et al. 1031P OCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer. Annals of Oncology. 2019;30(Supplement_5):421.